Article metrics

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

 

Online download statistics by month:

Online download statistics by month: October 2021 to October 2021

AbstractFullPdf
Oct 202116251604920
Total16251604920